CM
CLGN icon

Cohanzick Management’s CollPlant Biotechnologies CLGN Stock Holding History

Cohanzick Management’s Portfolio CLGN Stock Details CLGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,000
Closed -$14K – 198
2022
Q3 		$14K Hold
2,000
– – ﹤0.01% 272
2022
Q2 		$16K Buy
+2,000
New +$18.4K ﹤0.01% 317

Other funds holding CLGN

RAM
Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return
IMOV
Investment Management of Virginia Richmond, Virginia $526M AUM 3.23% 1-Year Est. Return
SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
BFEC
Benjamin F. Edwards & Company St. Louis, Missouri $5.69B AUM 15.37% 1-Year Est. Return
Zurich Cantonal Bank
Zurich Cantonal Bank Zurich, Switzerland $46B AUM 27.59% 1-Year Est. Return
SQA
Simon Quick Advisors Morristown, New Jersey $2.19B AUM 17.29% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Cohanzick Management's CLGN Position: Q4 2022 in Review

Cohanzick Management sold out of CollPlant Biotechnologies (CLGN) in Q4 2022, closing a stake of 2,000 shares — an estimated $14K sold.

Cohanzick Management first reported a position in CLGN in Q2 2022 and held it in 2 quarters. The position peaked at $16K in Q2 2022. 18 funds tracked by Wall St. Rank hold CLGN as of Q4 2022.

  • Cohanzick Management reported no remaining CollPlant Biotechnologies position as of Q4 2022 after selling out during the quarter.
  • Cohanzick Management sold 2,000 CollPlant Biotechnologies shares in Q4 2022, an estimated $14K.
  • Cohanzick Management first reported a position in CollPlant Biotechnologies in Q2 2022 and held it in 2 quarters.
  • Cohanzick Management's CollPlant Biotechnologies position peaked at $16K in Q2 2022.
  • 18 funds tracked by Wall St. Rank held CollPlant Biotechnologies as of Q4 2022.

Based on Cohanzick Management's 13F filing for Q4 2022, filed 13 Feb 2023.